Bioprinting is considered a key technology for future space missions and is currently being established on the International Space Station (ISS). With the aim to perform bioink production as a critical and resource‐consuming preparatory step already on Earth and transport a bioink cartridge “ready to use” to the ISS, the storability of bioinks is investigated. Hydrogel blends based on alginate and methylcellulose are laden with either green microalgae of the species Chlorella vulgaris or with different human cell lines including immortilized human mesenchymal stem cells, SaOS‐2 and HepG2, as well as with primary human dental pulp stem cells. The bioinks are filled into printing cartridges and stored at 4°C for up to four weeks. Printability of the bioinks is maintained after storage. Viability and function of the cells embedded in constructs bioprinted from the stored bioinks are investigated during subsequent cultivation: The microalgae survive the storage period very well and show no loss of growth and functionality, however a significant decrease is visible for human cells, varying between the different cell types. The study demonstrates that storage of bioinks is in principle possible and is a promising starting point for future research, making complex printing processes more effective and reproducible.
Highly viscous bioinks offer great advantages for the three-dimensional fabrication of cell-laden constructs by microextrusion printing. However, no standardised method of mixing a high viscosity biomaterial ink and a cell suspension has been established so far, leading to non-reproducible printing results. A novel method for the homogeneous and reproducible mixing of the two components using a mixing unit connecting two syringes is developed and investigated. Several static mixing units, based on established mixing designs, were adapted and their functionality was determined by analysing specific features of the resulting bioink. As a model system, we selected a highly viscous ink consisting of fresh frozen human blood plasma, alginate, and methylcellulose, and a cell suspension containing immortalized human mesenchymal stem cells. This bioink is crosslinked after fabrication. A pre-crosslinked gellan gum-based bioink providing a different extrusion behaviour was introduced to validate the conclusions drawn from the model system. For characterisation, bioink from different zones within the mixing device was analysed by measurement of its viscosity, shape fidelity after printing and visual homogeneity. When taking all three parameters into account, a comprehensive and reliable comparison of the mixing quality was possible. In comparison to the established method of manual mixing inside a beaker using a spatula, a significantly higher proportion of viable cells was detected directly after mixing and plotting for both bioinks when the mixing unit was used. A screw-like mixing unit, termed “HighVisc”, was found to result in a homogenous bioink after a low number of mixing cycles while achieving high cell viability rates.
The transplantation of pancreatic islets can prevent severe long-term complications in diabetes mellitus type 1 patients. With respect to a shortage of donor organs, the transplantation of xenogeneic islets is highly attractive. To avoid rejection, islets can be encapsulated in immuno-protective hydrogel-macrocapsules, whereby 3D bioprinted structures with macropores allow for a high surface-to-volume ratio and reduced diffusion distances. In the present study, we applied 3D bioprinting to encapsulate the potentially clinically applicable neonatal porcine islet-like cell clusters (NICC) in alginate-methylcellulose. The material was additionally supplemented with bovine serum albumin or the human blood plasma derivatives platelet lysate and fresh frozen plasma. NICC were analysed for viability, proliferation, the presence of hormones, and the release of insulin in reaction to glucose stimulation. Bioprinted NICC are homogeneously distributed, remain morphologically intact, and show a comparable viability and proliferation to control NICC. The number of insulin-positive cells is comparable between the groups and over time. The amount of insulin release increases over time and is released in response to glucose stimulation over 4 weeks. In summary, we show the successful bioprinting of NICC and could demonstrate functionality over the long-term in vitro. Supplementation resulted in a trend for higher viability, but no additional benefit on functionality was observed.
The development of mechanically robust, cell‐instructive, and seweable small‐diameter (≤ Ø 6 mm) tubular scaffolds remain a major challenge in vascular tissue engineering. Here, a hybrid biofabrication strategy is presented that combines 4D printing of alginate‐methylcellulose (AlgMC) hydrogels with melt electrowritten (MEW) poly(ε‐caprolactone) (PCL) reinforcement to produce tubular constructs with programmable shape‐morphing capacity. The MEW fiber meshes significantly improve mechanical integrity, enabling suturing and perfusion, while preserving the anisotropic swelling behavior required for morphogenesis. Scaffold functionalization using human blood‐derived protein coatings — such as fresh frozen plasma, platelet lysate, and fibrinogen — markedly enhances cellular adhesion and fibroblast proliferation without compromising structural transformation. Biological evaluation using mono and co‐cultures of fibroblasts, endothelial cells (HUVEC), and vascular smooth muscle cells (vSMC) reveals the formation of organized bi‐layers and phenotype‐specific cell morphologies on AlgMC/PCL composites. Notably, a confluent endothelial layer promotes contractile marker expression in vSMC, while vSMC support endothelial coverage in the absence of a growth‐arrested fibroblast feeder layer, indicating reciprocal stabilization. While further optimization is needed to meet the demands of small‐diameter vascular grafts fully, the presented system offers a versatile and promising platform for engineering soft tissue constructs that benefit from topographical guidance, spatially controlled adhesion, and adaptive geometry.
The kidneys are vital for maintaining bodily homeostasis and are susceptible to various diseases that disrupt their function. Traditionally, research on kidney diseases has relied on animal models and simplistic two-dimensional cell cultures, which do not fully replicate human tissue pathology. To address this, recent advances focus on developing advanced 3D biomimetic in vitro models using human-derived cells. These models mimic healthy and diseased kidney tissues with specificity, replicating key elements like glomerular and tubular structures through tissue engineering. By closely mimicking human physiology, they provide a promising platform for studying renal disorders, drug-induced nephrotoxicity, and evaluating new therapies. However, the challenges include optimizing scalability, reproducibility, and long-term stability to enhance reliability in research and clinical applications. This review highlights the transformative potential of 3D biomimetic in vitro kidney models in advancing biomedical research and clinical applications. By focusing on human-specific cell cultures and tissue engineering techniques, these models aim to overcome the limitations of conventional animal models and simplistic 2D cell cultures. The review discusses in detail the various types of biomimetic kidney models currently under development, their specific applications, and the innovative approaches used to construct them. It also addresses the challenges and limitations associated with these models for their widespread adoption and reliability in research settings.
Type 1 diabetes mellitus (T1D) is characterized by the autoimmune destruction of pancreatic beta cells, leading to insulin deficiency and necessitating lifelong external insulin administration. The transplantation of allogenic islets is a promising therapeutic approach, whereby their macro‐encapsulation offers immune protection but restricts oxygenation after transplantation. This study addresses the challenge of oxygen supply by developing a spatially structured co‐culture system using bioprinting, in which both pancreatic islets and the photosynthetically active microalga Scenedesmus sp. are embedded in alginate‐based hydrogels. Key environmental parameters for long‐term co‐cultivation were developed and systematically optimized: red light illumination was identified as non‐detrimental to islet viability and function while supporting microalgal photosynthesis at the same time, and a co‐culture medium was formulated to fulfill the metabolic requirements of both cell types. In direct co‐culture experiments under hypoxic conditions, microalgae generated sufficient oxygen to maintain normoxic conditions, thereby preserving islet viability and glucose‐stimulated insulin secretion over several days. The results demonstrate that spatially organized bioprinting enables the close proximity of islets and microalgae, facilitating effective oxygen transfer in vitro. This work establishes a robust framework for functional mammalian–microalgae co‐cultures, optimizing conditions to reliably maintain cell health and function through photosynthetically generated oxygen.